ADA Partners with DEA on Opioid Epidemic Webinar
The ADA and DEA are offering a three-part webinar series on the proper handling of controlled substances to combat the opioid epidemic.
The ADA and DEA are offering a three-part webinar series on the proper handling of controlled substances to combat the opioid epidemic.
The FDA has released new guidance stating clear aligners are not authorized for direct-to-consumer sales without a prescription and dental supervision, citing increased risk of complications without professional oversight.